Eosinophil cationic protein stimulates migration of human lung fibroblasts in vitro

Scandinavian Journal of Immunology

Volumn 69, Issue 4, 2009, Pages 381-386

  Zagai, U ^a   Lundahl, J ^a   Klominek, J ^a   Venge, P ^b   Skold C M ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

EOSINOPHIL CATIONIC PROTEIN; NEUTRALIZING ANTIBODY;

AIRWAY; ARTICLE; ASTHMA; CELL MIGRATION; CHROMATOGRAPHY; CONCENTRATION RESPONSE; CONTROLLED STUDY; EOSINOPHIL; EXTRACELLULAR MATRIX; GEL FILTRATION; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATION; ION EXCHANGE; LUNG FIBROBLAST; LUNG FIBROSIS; PRIORITY JOURNAL;

ASTHMA; CELL MOVEMENT; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; EOSINOPHIL CATIONIC PROTEIN; FIBROBLASTS; HUMANS; LUNG; PULMONARY FIBROSIS;

EID: 61849134308     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2009.02233.x     Document Type: Article

References (26)

1. Wilson JW, Bamford TL. Assessing the evidence for remodelling of the airway in asthma. Pulm Pharmacol Ther 2001 14 : 229 47.
2. Bousquet J, Chanez P, Lacoste JY et al. Eosinophilic inflammation in asthma. N Engl J Med 1990 323 : 1033 9.
3. Venge P, Bystrom J, Carlson M et al. Eosinophil cationic protein (ECP): molecular and biological properties and the use of ECP as a marker of eosinophil activation in disease. Clin Exp Allergy 1999 29 : 1172 86.
4. Martin LB, Kita H, Leiferman KM, Gleich GJ. Eosinophils in allergy: role in disease, degranulation, and cytokines. Int Arch Allergy Immunol 1996 109 : 207 15.
5. Venge P. Monitoring the allergic inflammation. Allergy 2004 59 : 26 32.
6. Flood-Page P, Menzies-Gow A, Phipps S et al. Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics. J Clin Invest 2003 112 : 1029 36.
7. Zagai U, Skold CM, Trulson A, Venge P, Lundahl J. The effect of eosinophils on collagen gel contraction and implications for tissue remodelling. Clin Exp Immunol 2004 135 : 427 33.
8. Humbles AA, Lloyd CM, McMillan SJ et al. A critical role for eosinophils in allergic airways remodeling. Science 2004 305 : 1776 9.
9. Sime P, Tremblay G, Xing Z, Sarnstrand B, Gauldie J. Interstitial and bronchial fibroblasts. In : Barnes P, Grunstein M, Leff A, Woolcock A, eds. Asthma. Philadelphia, PA : Lippincott-Raven Publishers, 1997 : 475 89.
10. Leeb SN, Vogl D, Falk W, Scholmerich J, Rogler G, Gelbmann CM. Regulation of migration of human colonic myofibroblasts. Growth Factors 2002 20 : 81 91.
11. Batra V, Musani AI, Hastie AT et al. Bronchoalveolar lavage fluid concentrations of transforming growth factor (TGF)-beta1, TGF-beta2, interleukin (IL)-4 and IL-13 after segmental allergen challenge and their effects on alpha-smooth muscle actin and collagen III synthesis by primary human lung fibroblasts. Clin Exp Allergy 2004 34 : 437 44.
12. Diegelmann RF, Evans MC. Wound healing: an overview of acute, fibrotic and delayed healing. Front Biosci 2004 9 : 283 9.
13. Zagai U, Fredriksson K, Rennard SI, Lundahl J, Skold CM. Platelets stimulate fibroblast-mediated contraction of collagen gels. Respir Res 2003 4 : 13.
14. Peterson CG, Jornvall H, Venge P. Purification and characterization of eosinophil cationic protein from normal human eosinophils. Eur J Haematol 1988 40 : 415 23.
15. Trulson A, Bystrom J, Engstrom A, Larsson R, Venge P. The functional heterogeneity of eosinophil cationic protein is determined by a gene polymorphism and post-translational modifications. Clin Exp Allergy 2007 37 : 208 18.
16. Boyden S. The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leucocytes. J Exp Med 1962 115 : 453 66.
17. Liu Z, Klominek J. Inhibition of proliferation, migration, and matrix metalloprotease production in malignant mesothelioma cells by tyrosine kinase inhibitors. Neoplasia 2004 6 : 705 12.
18. Montgomery DC. Design and analysis of experiments, 3rd edn. New York : John Wiley & Sons, 1991.
19. Daniel WW. Biostatistics: a foundation for analysis in the health sciences, 6th edn. New York : John Wiley & Sons, 1995.
20. Howell JE, McAnulty RJ. TGF-beta: its role in asthma and therapeutic potential. Curr Drug Targets 2006 7 : 547 65.
21. Minshall EM, Leung DY, Martin RJ et al. Eosinophil-associated TGF-beta1 mRNA expression and airways fibrosis in bronchial asthma. Am J Respir Cell Mol Biol 1997 17 : 326 33.
22. Schreier T, Degen E, Baschong W. Fibroblast migration and proliferation during in vitro wound healing. A quantitative comparison between various growth factors and a low molecular weight blood dialysate used in the clinic to normalize impaired wound healing. Res Exp Med (Berl) 1993 193 : 195 205.
23. Kottler UB, Junemann AG, Aigner T, Zenkel M, Rummelt C, Schlotzer-Schrehardt U. Comparative effects of TGF-beta 1 and TGF-beta 2 on extracellular matrix production, proliferation, migration, and collagen contraction of human Tenon's capsule fibroblasts in pseudoexfoliation and primary open-angle glaucoma. Exp Eye Res 2005 80 : 121 34.
24. Zagai U, Dadfar E, Lundahl J, Venge P, Skold CM. Eosinophil cationic protein stimulates TGF-beta1 release by human lung fibroblasts in vitro. Inflammation 2007 30 : 153 60.
25. Kay AB. Asthma and inflammation. J Allergy Clin Immunol 1991 87 : 893 910.
26. Rutgers SR, Timens W, Kaufmann HF, van der Mark TW, Koeter GH, Postma DS. Comparison of induced sputum with bronchial wash, bronchoalveolar lavage and bronchial biopsies in COPD. Eur Respir J 2000 15 : 109 15.